Disclosures for "The 201 Trial in Untreated Parkinson's Disease"
-
Dr. Werner has received personal compensation for serving as an employee of Inhibikase Therapeutics, Inc.. Dr. Werner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Inhibikase Therapeutics, Inc.. Dr. Werner has stock in Inhibikase Therapeutics, Inc.. The institution of Dr. Werner has received research support from NIH, MJ Fox Foundation. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Olanow has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Chevron/Syngenta. Dr. Olanow has stock in Clintrex Research Corporation.
-
Dr. McGarry has nothing to disclose.
-
Mr. Meyer has received personal compensation for serving as an employee of Inhibikase Therapeutics.
-
Mrs. Mancino has received personal compensation for serving as an employee of Inhibikase Therapeutics. Mrs. Mancino has received personal compensation for serving as an employee of Ichnos Pharmaceuticals.
-
Mr. Klint has received personal compensation for serving as an employee of Inhibikase Therapeutics.
-
Miss Pellecchia has nothing to disclose.